TrialInternational journal of hematology2019

Clinical efficacy and safety of first-line nilotinib therapy and evaluation of the clinical utility of the FRET-based drug sensitivity test.

Takeshi Kondo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.